2023-12-12 09:10:02 ET
More on Sigyn Therapeutics, Inc.
For further details see:
Sigyn Therapeutics names Jerry DeCiccio as finance cheif2023-12-12 09:10:02 ET
For further details see:
Sigyn Therapeutics names Jerry DeCiccio as finance cheifMarket Wire News is a media platform, the information on this page was provided by SeekingAlpha via Quote Media. Read our full disclaimer.
When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
News, Short Squeeze, Breakout and More Instantly...
Sigyn Therapeutics (OTCQB: SIGY) , a development-stage medical technology company, today announced financial results for the first quarter ended March 31, 2024. During the quarter, the company reported a loss from operations of $629,972, as compared to an operating loss of $521,258 for the compar...
SAN DIEGO, CA - ( NewMediaWire ) - May 15, 2024 - Sigyn Therapeutics, Inc. (“Sigyn” or the “Company”) (OTCQB: SIGY), a development-stage medical technology company, today announced financial results for the first quarter ended March 31, 2024. During the quarter, the C...
Sigyn Therapeutics (OTCQB: SIGY) , a development-stage medical technology company, today announced that it has published an article entitled: “Sigyn Therapy(TM), an Emerging Candidate to Address Endotoxemia, Sepsis and Drug-Resistant Viral & Bacterial Infections.” “Wh...